Page last updated: 2024-11-03

rabeprazole and Cirrhosis, Liver

rabeprazole has been researched along with Cirrhosis, Liver in 3 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Research Excerpts

ExcerptRelevanceReference
"To investigate whether or not CYP2C19 genotype status is associated with cure rate for Helicobacter pylori infection in patients with cirrhosis and peptic ulcer, achieved with 2 weeks of triple therapy with rabeprazole, amoxicillin and clarithromycin."3.76Correlation of CYP2C19 genetic polymorphisms with helicobacter pylori eradication in patients with cirrhosis and peptic ulcer. ( Lay, CS; Lin, CJ; Lin, JR, 2010)
"Rabeprazole was well tolerated by both groups."2.69Rabeprazole: pharmacokinetics in patients with stable, compensated cirrhosis. ( Grimes, I; Hoyumpa, AM; Humphries, TJ; Trevino-Alanis, H, 1999)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsai, CF1
Chen, MH1
Wang, YP1
Chu, CJ1
Huang, YH1
Lin, HC1
Hou, MC1
Lee, FY1
Su, TP1
Lu, CL1
Lay, CS1
Lin, CJ1
Lin, JR1
Hoyumpa, AM1
Trevino-Alanis, H1
Grimes, I1
Humphries, TJ1

Trials

1 trial available for rabeprazole and Cirrhosis, Liver

ArticleYear
Rabeprazole: pharmacokinetics in patients with stable, compensated cirrhosis.
    Clinical therapeutics, 1999, Volume: 21, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Chronic Disease; Enzyme Inhibitors;

1999

Other Studies

2 other studies available for rabeprazole and Cirrhosis, Liver

ArticleYear
Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
    Gastroenterology, 2017, Volume: 152, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administrative Claims, Healthcare; Adult; Aged; Case-Contro

2017
Correlation of CYP2C19 genetic polymorphisms with helicobacter pylori eradication in patients with cirrhosis and peptic ulcer.
    Journal of the Chinese Medical Association : JCMA, 2010, Volume: 73, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithr

2010